EA201400970A1 - Новые композиции для лечения амиотрофического бокового склероза - Google Patents
Новые композиции для лечения амиотрофического бокового склерозаInfo
- Publication number
- EA201400970A1 EA201400970A1 EA201400970A EA201400970A EA201400970A1 EA 201400970 A1 EA201400970 A1 EA 201400970A1 EA 201400970 A EA201400970 A EA 201400970A EA 201400970 A EA201400970 A EA 201400970A EA 201400970 A1 EA201400970 A1 EA 201400970A1
- Authority
- EA
- Eurasian Patent Office
- Prior art keywords
- treatment
- amiotrophic
- new compositions
- side sclerosis
- sclerosis
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title abstract 2
- 208000034189 Sclerosis Diseases 0.000 title 1
- 206010002026 amyotrophic lateral sclerosis Diseases 0.000 abstract 2
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A61K31/138—Aryloxyalkylamines, e.g. propranolol, tamoxifen, phenoxybenzamine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A61K31/428—Thiazoles condensed with carbocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Epidemiology (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Pain & Pain Management (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Rheumatology (AREA)
- Emergency Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Lubricants (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
Настоящее изобретение имеет отношение к композициям и способам лечения амиотрофического бокового склероза. Конкретнее, настоящее изобретение имеет отношение к новым комбинированным способам лечения амиотрофического бокового склероза или родственного заболевания.
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PCT/EP2012/053570 WO2012117076A2 (en) | 2011-03-01 | 2012-03-01 | Baclofen and acamprosate based therapy of neurogical disorders |
PCT/EP2012/053565 WO2012117073A2 (en) | 2011-03-01 | 2012-03-01 | New compositions for treating neurological disorders |
EP13706548.8A EP2819664B1 (en) | 2012-03-01 | 2013-02-28 | New compositions for treating amyotrophic lateral sclerosis |
PCT/EP2013/054024 WO2013127917A1 (en) | 2011-03-01 | 2013-02-28 | New compositions for treating amyotrophic lateral sclerosis |
Publications (3)
Publication Number | Publication Date |
---|---|
EA201400970A1 true EA201400970A1 (ru) | 2015-02-27 |
EA031331B1 EA031331B1 (ru) | 2018-12-28 |
EA031331B9 EA031331B9 (ru) | 2019-02-28 |
Family
ID=47754536
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EA201400970A EA031331B9 (ru) | 2012-03-01 | 2013-02-28 | Комбинация акампросата, баклофена и рилузола для лечения амиотрофического бокового склероза и родственного заболевания |
Country Status (12)
Country | Link |
---|---|
EP (3) | EP3348261B1 (ru) |
JP (1) | JP6158234B2 (ru) |
CY (1) | CY1119195T1 (ru) |
EA (1) | EA031331B9 (ru) |
HR (1) | HRP20171206T1 (ru) |
HU (1) | HUE034212T2 (ru) |
LT (1) | LT2819664T (ru) |
PL (1) | PL2819664T3 (ru) |
PT (1) | PT2819664T (ru) |
RS (1) | RS56175B1 (ru) |
SI (1) | SI2819664T1 (ru) |
UA (1) | UA114811C2 (ru) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA3151459A1 (en) | 2019-09-20 | 2021-03-25 | Ana PEREIRA | Controlled release formulations of riluzole and their uses |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP3180381B2 (ja) * | 1991-08-31 | 2001-06-25 | ウェルファイド株式会社 | 抗アルドステロン作用剤 |
NZ589304A (en) * | 2008-04-29 | 2012-03-30 | Pharnext | Combination compositions for treating alzheimer disease and related disorders with zonisamide and acamprosate |
WO2009133141A2 (en) * | 2008-04-29 | 2009-11-05 | Pharnext | New therapeutic approaches for treating alzheimer disease and related disorders through a modulation of angiogenesis |
AU2009242127B2 (en) * | 2008-04-29 | 2014-03-27 | Pharnext | New therapeutic approaches for treating Alzheimer disease and related disorders through a modulation of cell stress response |
EP2322163A1 (en) * | 2009-11-03 | 2011-05-18 | Pharnext | New therapeutics approaches for treating alzheimer disease |
EP2705842A1 (en) * | 2012-09-05 | 2014-03-12 | Pharnext | Therapeutic approaches for treating parkinson's disease |
UA113165C2 (xx) * | 2011-03-01 | 2016-12-26 | Застосування комбінації баклофену і акампросату для лікування неврологічних захворювань та композиція, яка містить баклофен і акампросат | |
DK2560631T3 (da) * | 2011-03-01 | 2014-02-10 | Pharnext | Baclofen- og acamprosat-baseret af neurologiske forstyrrelser |
EP2727587A1 (en) * | 2012-10-30 | 2014-05-07 | Pharnext | Compositions, methods and uses for the treatment of diabetes and related conditions by controlling blood glucose level |
-
2013
- 2013-02-28 UA UAA201410678A patent/UA114811C2/uk unknown
- 2013-02-28 PL PL13706548T patent/PL2819664T3/pl unknown
- 2013-02-28 EP EP18157222.3A patent/EP3348261B1/en active Active
- 2013-02-28 LT LTEP13706548.8T patent/LT2819664T/lt unknown
- 2013-02-28 EP EP17173296.9A patent/EP3235498A1/en not_active Withdrawn
- 2013-02-28 RS RS20170807A patent/RS56175B1/sr unknown
- 2013-02-28 EP EP13706548.8A patent/EP2819664B1/en active Active
- 2013-02-28 JP JP2014559213A patent/JP6158234B2/ja not_active Expired - Fee Related
- 2013-02-28 SI SI201330727T patent/SI2819664T1/sl unknown
- 2013-02-28 PT PT137065488T patent/PT2819664T/pt unknown
- 2013-02-28 EA EA201400970A patent/EA031331B9/ru not_active IP Right Cessation
- 2013-02-28 HU HUE13706548A patent/HUE034212T2/en unknown
-
2017
- 2017-08-07 HR HRP20171206TT patent/HRP20171206T1/hr unknown
- 2017-08-08 CY CY20171100849T patent/CY1119195T1/el unknown
Also Published As
Publication number | Publication date |
---|---|
JP6158234B2 (ja) | 2017-07-05 |
RS56175B1 (sr) | 2017-11-30 |
EP3235498A1 (en) | 2017-10-25 |
UA114811C2 (uk) | 2017-08-10 |
PL2819664T3 (pl) | 2017-12-29 |
HRP20171206T1 (hr) | 2017-10-20 |
EP3348261A1 (en) | 2018-07-18 |
EP3348261B1 (en) | 2020-10-21 |
LT2819664T (lt) | 2017-10-25 |
EA031331B1 (ru) | 2018-12-28 |
EA031331B9 (ru) | 2019-02-28 |
EP2819664A1 (en) | 2015-01-07 |
PT2819664T (pt) | 2017-08-24 |
SI2819664T1 (sl) | 2017-12-29 |
HUE034212T2 (en) | 2018-02-28 |
CY1119195T1 (el) | 2018-02-14 |
EP2819664B1 (en) | 2017-05-31 |
JP2015508797A (ja) | 2015-03-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EA201891833A1 (ru) | Комбинация для лечения амиотрофического бокового склероза или родственных болезней | |
MX2019011905A (es) | Nuevas composiciones para el tratamiento de la esclerosis lateral amiotrofica. | |
EA201490423A1 (ru) | СПОСОБЫ И КОМПОЗИЦИИ, ОТНОСЯЩИЕСЯ К p62, ДЛЯ ЛЕЧЕНИЯ И ПРОФИЛАКТИКИ РАКА | |
PH12015502075B1 (en) | Treatment of cataplexy | |
TR201901886T4 (tr) | DNA-PK inhibitörleri. | |
EA201201374A1 (ru) | Лечение атаксии-телеангиэктазии | |
EA201790273A1 (ru) | Флагеллиновые композиции и их применение | |
EA201491151A1 (ru) | Соединения, ингибирующие металлоферменты | |
EA201591746A1 (ru) | Способы и композиции для ингибирования бромодомен-содержащих белков | |
EA201491412A1 (ru) | Соединения для лечения спинальной мышечной атрофии | |
EA201491766A1 (ru) | Соединения для лечения спинальной мышечной атрофии | |
EA201690007A1 (ru) | Соединения, ингибирующие металлоферменты | |
EA201491811A1 (ru) | АНТИ-LgR5 АНТИТЕЛА И ИММУНОКОНЪЮГАТЫ | |
MX2013015158A (es) | Compuestos inhibidores de metaloenzima. | |
EA201391248A1 (ru) | Биспецифические связывающие агенты | |
EA201592157A1 (ru) | Низкомолекулярные ингибиторы фиброза | |
EA201490944A1 (ru) | Двойной ингибитор met и vegf для лечения рака | |
EA201101686A1 (ru) | Новые композиции для лечения шмт и связанных с ней расстройств | |
EA201590270A1 (ru) | Применение биотина для лечения рассеянного склероза | |
MX2013006875A (es) | Anticuepos anti-notch1. | |
EA201690039A1 (ru) | Ингибиторы rorc2 и способы их применения | |
EA201201296A1 (ru) | Способы лечения диабетических язв стопы | |
EA201491500A1 (ru) | Способы лечения фиброза | |
EA201690783A1 (ru) | Вещества, фармацевтическая композиция и методы применения при лечении воспалительных заболеваний | |
PH12016500903A1 (en) | Novel methods for treating neurodegenerative diseases |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
TH4A | Publication of the corrected specification to eurasian patent | ||
MM4A | Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s) |
Designated state(s): AM KG TJ TM |
|
MM4A | Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s) |
Designated state(s): AZ BY KZ RU |